{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T03:58:34Z","timestamp":1794455914565,"version":"4.9.1"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5,1]]},"DOI":"10.1093\/cid\/cix135","type":"journal-article","created":{"date-parts":[[2017,2,15]],"date-time":"2017-02-15T03:57:10Z","timestamp":1487131030000},"page":"1228-1235","source":"Crossref","is-referenced-by-count":171,"title":["Carcinogenicity of Human Papillomavirus (HPV) Types in HIV-Positive Women: A Meta-Analysis From HPV Infection to Cervical Cancer"],"prefix":"10.1093","volume":"64","author":[{"given":"Gary M.","family":"Clifford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Tully","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Franceschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,2,12]]},"reference":[{"key":"key\n\t\t\t\t20170418093833_CIT0001","first-page":"1","article-title":"Biological agents","volume":"100B","author":"International Agency for Research on Cancer","year":"2012","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"key":"key\n\t\t\t\t20170418093833_CIT0002","doi-asserted-by":"crossref","unstructured":"Guan P Howell-Jones R Li N . Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int J Cancer2012; 131:2349\u201359.","DOI":"10.1002\/ijc.27485"},{"key":"key\n\t\t\t\t20170418093833_CIT0003","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1750-9378-4-8","article-title":"Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline","volume":"4","year":"2009","journal-title":"Infect Agent Cancer"},{"key":"key\n\t\t\t\t20170418093833_CIT0004","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1158\/1055-9965.EPI-11-0206","article-title":"A long-term prospective study of type-specific human papillomavirus infection and risk of cervical neoplasia among 20,000 women in the Portland Kaiser Cohort Study","volume":"20","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key\n\t\t\t\t20170418093833_CIT0005","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1158\/1055-9965.EPI-14-1353","article-title":"The role of human papillomavirus genotyping in cervical cancer screening: a large-scale evaluation of the Cobas HPV test","volume":"24","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key\n\t\t\t\t20170418093833_CIT0006","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1093\/jnci\/djq356","article-title":"Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence","volume":"102","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t20170418093833_CIT0007","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1097\/QAD.0000000000000455","article-title":"Long-term cumulative detection of human papillomavirus among HIV seropositive women","volume":"28","year":"2014","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170418093833_CIT0008","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1086\/520883","article-title":"The impact of HIV status and type on the clearance of human papillomavirus infection among Senegalese women","volume":"196","year":"2007","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170418093833_CIT0009","doi-asserted-by":"crossref","first-page":"606.e1","DOI":"10.1016\/j.ajog.2014.12.003","article-title":"Incidence of cervical precancers among HIV-seropositive women","volume":"212","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"key\n\t\t\t\t20170418093833_CIT0010","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1002\/ijc.29913","article-title":"Immunodeficiency and the risk of cervical intraepithelial neoplasia 2\/3 and cervical cancer: a nested case-control study in the Swiss HIV cohort study","volume":"138","author":"Swiss HIV Cohort Study","year":"2016","journal-title":"Int J Cancer"},{"key":"key\n\t\t\t\t20170418093833_CIT0011","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.1097\/QAI.0b013e31829cb7c3","article-title":"Invasive cervical cancer risk among HIV-infected women is a function of CD4 count and screening","volume":"63","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20170418093833_CIT0012","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0140-6736(07)61050-2","article-title":"Incidence of cancers in people with HIV\/AIDS compared with immunosuppressed transplant recipients: a meta-analysis","volume":"370","year":"2007","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170418093833_CIT0013","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1093\/jnci\/95.14.1062","article-title":"Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women","volume":"95","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t20170418093833_CIT0014","doi-asserted-by":"crossref","first-page":"e13525","DOI":"10.1371\/journal.pone.0013525","article-title":"Risk factors for cervical precancer and cancer in HIV-infected, HPV-positive Rwandan women","volume":"5","year":"2010","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170418093833_CIT0015","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1097\/01.aids.0000253361.63578.14","article-title":"Human papillomavirus types among women infected with HIV: a meta-analysis","volume":"20","author":"HPV and HIV Study Group","year":"2006","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170418093833_CIT0016","first-page":"354.e1-6","article-title":"Association of cervical precancer with human papillomavirus types other than 16 among HIV co-infected women","volume":"214","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"key\n\t\t\t\t20170418093833_CIT0017","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/QAI.0000000000001113","article-title":"Effect of HIV infection on human papillomavirus types causing invasive cervical cancer in Africa","volume":"73","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20170418093833_CIT0018","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/cid\/civ569","article-title":"Cervical precancer risk in HIV-infected women who test positive for oncogenic human papillomavirus despite a normal Pap test","volume":"61","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170418093833_CIT0019","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1002\/ijc.25723","article-title":"Adenocarcinoma in situ and associated human papillomavirus type distribution observed in two clinical trials of a quadrivalent human papillomavirus vaccine","volume":"128","author":"FUTURE I and II Study Group","year":"2011","journal-title":"Int J Cancer"},{"key":"key\n\t\t\t\t20170418093833_CIT0020","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/jnci\/djr283","article-title":"Persistence of type-specific human papillomavirus infection and increased long-term risk of cervical cancer","volume":"103","author":"CBCSP-HPV Study Group","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t20170418093833_CIT0021","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1086\/657321","article-title":"Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings","volume":"202","year":"2010","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170418093833_CIT0022","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3322\/caac.21139","article-title":"American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer","volume":"62","author":"ACS-ASCCP-ASCP Cervical Cancer Guideline Committee","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"key\n\t\t\t\t20170418093833_CIT0023","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ygyno.2014.12.022","article-title":"Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance","volume":"136","year":"2015","journal-title":"Gynecol Oncol"},{"key":"key\n\t\t\t\t20170418093833_CIT0024","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ygyno.2014.11.076","article-title":"Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test","volume":"136","year":"2015","journal-title":"Gynecol Oncol"},{"key":"key\n\t\t\t\t20170418093833_CIT0025","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ygyno.2010.04.013","article-title":"Clinical validation of the Cervista HPV HR and 16\/18 genotyping tests for use in women with ASC-US cytology","volume":"118","year":"2010","journal-title":"Gynecol Oncol"},{"key":"key\n\t\t\t\t20170418093833_CIT0026","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1128\/JCM.00176-14","article-title":"Clinical evaluation of the cartridge-based GeneXpert human papillomavirus assay in women referred for colposcopy","volume":"52","year":"2014","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20170418093833_CIT0027","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ijgo.2015.07.038","article-title":"World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2-3 and screen-and-treat strategies to prevent cervical cancer","volume":"132","author":"Guideline Support Group","year":"2016","journal-title":"Int J Gynaecol Obstet"},{"key":"key\n\t\t\t\t20170418093833_CIT0028","first-page":"362","article-title":"Risk of cervical precancer and cancer among HIV-infected women with normal cervical cytology and no evidence of oncogenic HPV infection","volume":"308","year":"2012","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170418093833_CIT0029","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1750-9378-9-40","article-title":"Prevalence and risk factors for high-risk human papillomavirus (hrHPV) infection among HIV-infected and uninfected Rwandan women: implications for hrHPV-based screening in Rwanda","volume":"9","year":"2014","journal-title":"Infect Agent Cancer"},{"key":"key\n\t\t\t\t20170418093833_CIT0030","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1097\/01.aids.0000432472.92120.1b","article-title":"Comparing Papanicolau smear, visual inspection with acetic acid and human papillomavirus cervical cancer screening methods among HIV-positive women by immune status and antiretroviral therapy","volume":"27","year":"2013","journal-title":"AIDS"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/64\/9\/1228\/13635209\/cix135.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T14:54:15Z","timestamp":1503586455000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article-lookup\/doi\/10.1093\/cid\/cix135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,12]]},"references-count":30,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2017,2,12]]},"published-print":{"date-parts":[[2017,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/cix135","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727565191.793546767","asserted-by":"object"}]},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,12]]}}}